Quite recently, 2 RNA-binding proteins (RBPs)—FXR1 and IGF2BP2—were identified as key signal transduction mechanisms altered by niclosamide in ovarian cancer [60]. The gene discussed is IGF2BP2; the disease is ovarian carcinoma.